INNsight Newsletter - September Edition

INNsight Newsletter - September Edition

Welcome to the September edition of INNsight Newsletter, where we share with you the latest news and insights from?IQVIA Global Market Insights.?

This month's thought leadership includes:

  • Obesity: Key Pipeline Developments and Clinical Trial Insights
  • Surge in ADC Deals Drives Oncology Dealmaking
  • Achieving Oncology Launch Excellence
  • Webinar: ChannelDynamics? Verbatim with IQVIA AI Assistant - Transforming HCP Message Recall Analysis



Obesity: Key Pipeline Developments and Clinical Trial Insights

Over the years, several anti-obesity medications (AOM) have reached the market but failed after widespread use due to serious adverse effects, including cardiovascular events, suicidality, abuse, dependence, and cancer. This article provides an update on current treatment options for obesity and outlines the latest development activities, including ongoing clinical trials of key experimental drugs. Learn more



Surge in ADC Deals Drives Oncology Dealmaking

In recent years, antibody-drug conjugates (ADCs) have increasingly become more prominent in dealmaking, as leading industry players look to gain access to the transformative drug modalities. Notably, there was a marked increase in ADC deal volume from 2022 to 2023, with ADCs being the key drivers of several high-profile deals, particularly focused on oncology indications in the discovery and preclinical phases of development.?Learn more


Achieving Oncology Launch Excellence

Achieving Launch Excellence in oncology is increasingly challenging. Innovators face overwhelming complexity, opportunity fragmentation and a widening 'innovation readiness' gap, as healthcare systems cannot keep up with the pace of oncology innovation to effectively adopt new therapies.??This white paper explores the key factors for helping pharmaceutical companies navigate these harsh realities to achieve commercial success in oncology today and in future. Learn more



ChannelDynamics? Verbatim with IQVIA AI Assistant: Transforming HCP Message Recall Analysis

Webinar: Tuesday, October 29, 2024, 10:00 AM EDT, 45 minutes

Understanding healthcare professionals' (HCPs) perceptions of your and your competitors' brand messaging is crucial for adapting your marketing plans for maximum impact. Join us for this exclusive webinar where we unveil IQVIA ChannelDynamics? Verbatim with AI Assistant, our innovative new tool leveraging healthcare-grade AI? to discover how identifying which messages and themes resonate with HCPs can help optimize your brand planning and accelerate your marketing strategies. Register now


To learn about IQVIA Global Market Insights' solutions and how we can support your business, follow this link.



要查看或添加评论,请登录

社区洞察

其他会员也浏览了